Muscle Strength after Resistance Training Is Inversely Correlated with Baseline Levels of Soluble Tumor Necrosis Factor Receptors in the Oldest Old

Journal of the American Geriatrics Society

Volumn 52, Issue 2, 2004, Pages 237-241

  Bruunsgaard, Helle ^a,e   Bjerregaard, Eva ^c,d   Schroll, Marianne ^d   Pedersen, Bente Klarlund ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c HVIDOVRE HOSPITAL   (Denmark)

^d BISPEBJERG HOSPITAL   (Denmark)

^e Rigshospitalet   (Denmark)

Author keywords

Antiinflammatory activity; IL 6; Low grade inflammation; Resistance exercise; TNF

Indexed keywords

CYTOKINE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1;

AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD SMEAR; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DENMARK; FEMALE; HUMAN; INFLAMMATION; KNEE FUNCTION; MALE; MUSCLE STRENGTH; NURSING HOME; SAMPLE SIZE; SOCIAL BEHAVIOR; TRAINING;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; EXERCISE; FEMALE; FRAIL ELDERLY; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MUSCLE, SKELETAL; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 1242306999     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2004.52061.x     Document Type: Article

References (27)

1. Bruunsgaard H, Pedersen M, Pedersen BK. Aging and proinflammatory cytokines. Curr Opin Hematol 2001;8:131-136.
2. Volparo G, Guralnik JM, Ferrucci L et al. Cardiovascular disease, interleukin and risk of mortality in older women: The women's health and aging study. Circulation 2001:103:947-953.
3. Harris TB, Ferrucci L, Tracy RP et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999;106:506-512.
4. Reuben DB, Cheh AI, Harris TB et al. Peripheral blood markers of inflammation predict mortality and functional decline in high-functioning community-dwelling older persons. J Am Geriatr Soc 2002;50:638-644.
5. Bruumsgaard H, Ladelund S, Pedersen AN et al. Predicting death from TNF-α and IL-6 in 80-year-old people. Clin Exp Immunol 2003;132:24-31.
6. Hamerman D. Toward an understanding of frailty. Ann Intern Med 1999;130:945-950.
7. Visser M, Pahor M, Taaffe DR et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: The Health ABC Study. J Gerontol A Biol Sci Med Sci 2002;57A:M326-M332.
8. Ferrucci L, Harris TB, Guralnik JM et al. Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc 1999;47:639-646.
9. Xing Z, Gauldie J, Cox G et al. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 1998;101:311-320.
10. Tilg H, Dinarello CA, Mier JW. IL-6 and APPs: Antiinflammarory and immunosuppressive mediators. Immunol Today 1997;18:428-432.
11. Saves M, Morlat P, Chene G et al. Prognostic value of plasma markers of immune activation in patients with advanced HIV disease treated by combination antiretroviral therapy. Clin Immunol 2001;99:347-352.
12. Ferrari R, Bacherri T, Confortini R et al. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 1995;92:1479-1486.
13. Fiatarone MA, Marks EC, Ryan ND et al. High-intensity strength training in nonagenarians. Fffects on skeletal muscle. JAMA 1990;263:3029-3034.
14. Febbraio MA, Pedersen BK. Muscle-derived interleukin-6. Mechanisms for activation and possible biological roles. FASEB J 2002;16:1335-1347.
15. Pedersen BK, Bruunsgaard H. Possible beneficial role of exercise in modulating low-grade inflammation in the elderly. Scand J Med Sci Sports Res 2003;13:56-62.
16. Greiwe JS, Cheng B, Rubin DC et al. Resistance exercise decreases skeletal muscle tumor necrosis factor alpha in frail elderly humans. FASEB J 2001;15:475-482.
17. Harridge SD, Kryger A, Stensgaard A. Knee extensor strength, activation, and size in very elderly people following strength training. Muscle Nerve 1999;22:831-839.
18. Richards C, Gauldie J. Role of cytokines in the acute-phase response. In: Aggarwal BB, Puri RK, eds. Human Cytokines: Their Roles in Disease and Therapy. Cambridge, MA: Blackwell Science, 1995, pp 253-269.
19. Reid MB, Li YP. Tumor necrosis factor-alpha and muscle wasting: A cellular perspective. Respir Res 2001;2:269-272.
20. Tisdale MJ. Wasting in cancer. J Nutr 1999;129:243S-246S.
21. Roubenoff R, Grinspoon S, Skolnik PR et al. Role of cytokines and testosterone in regulating lean body mass and resting energy expenditure in HIV-infected men. Am J Physiol Endocrinol Metab 2002;283:E138-E145.
22. Roubenoff R, Roubenoff RA, Cannon JG et al. Rheumatoid cachexia: Cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest 1994;93:2379-2386.
23. Lynch NA, Metter EJ, Lindle RS et al. Muscle quality. 1. Age-associated differences between arm and leg muscle groups. J Appl Physiol 1999;86:188-194.
24. Frontera WR, Hughes VA, Fielding RA et al. Aging of skeletal muscle: A 12-yr longitudinal study. J Appl Physiol 2000;88:1321-1326.
25. Schroll M, Avlund K, Davidsen M. Predictors of five-year functional ability in a longitudinal survey of men and women aged 75-80. The 1914-population in Glostrup, Denmark. Aging Milano 1997;9:143-152.
26. Rantanen T, Guralnik JM, Ferrucci L et al. Coimpairments as predictors of severe walking disability in older women. J Am Geriatr Soc 2001;49:21-27.
27. Rall LC, Roubenoff R, Cannon JG et al. Effects of progressive resistance training on immune response in aging and chronic inflammation. Med Sci Sports Exerc 1996;28:1356-1365.